← All Nephros INC filings

Nephros INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
NEPH
Nephros INC
DEFA14A: Nephros, Inc. Files Definitive Proxy Statement with SEC
Nephros, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) related to its upcoming shareholder meeting.
NASDAQ
NEPH
Nephros INC
DEF: Nephros, Inc. Announces Annual Meeting of Stockholders and Director Nomination
Nephros, Inc. will hold its annual meeting virtually on June 16, 2025, to elect a director, ratify the appointment of its accounting firm, and approve executive compensation.
NASDAQ
NEPH
Nephros INC
DEFA14A: Nephros, Inc. Files Definitive Proxy Statement with SEC
Nephros, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
NEPH
Nephros INC
DEF 14A: Nephros, Inc. Seeks Stockholder Approval for Director Elections, Auditor Ratification, Equity Incentive Plan, and Executive Compensation
Nephros, Inc. is holding its annual meeting of stockholders on May 23, 2024, to vote on key proposals including the election of directors, ratification of the auditor, approval of an equity incentive plan, and an advisory vote on executive compensation.